Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: jm2i123 who wrote (11734)	1/21/2013 1:28:54 PM
From: NTTG	1 Recommendation Read Replies (1) \| Respond to of 13111

jm...the beauty of your approach is that you can buy and sell many times over before PVCT gets serious about the end game, taking advantage of all the hype and manipulation along the way, and still not miss out on anything big. My entry points in 2013 are lower than they were in 2010, hard to see progress there, but I am ahead financially. The poor game here is to buy and hold for 8-10 years, your ROI (which will only be realized for the first time at the end of the PIII trial when you can actually see how PV-10 compares to another therapy) will be worse than current bank interest rates. Longs who may not have understood the limitations associated with lack of scientific evidence got a clear look at PVCT through their failed aspiration for a NASDAQ IPO attempt.